The crew from Futurism visited Berkeley to learn more about the heart chip work in the Healy Lab. During their visit, the Healy Lab team showed Luke Robert Mason how they are combining cutting edge microfabrication techniques and stem cell biology to create human cardiac microphysiological systems that can be used as a drug-screening tool. The team aims to prove these devices can significantly reduce the cost and time to bring new medications to patients.
May 27, 2016
In 2012, a revolutionary new “DNA scissors” technology, referred to as CRISPR/Cas9, was discovered at UC Berkeley by Jennifer Doudna. Doudna talks about how the technology works and its applications for the future.
QB3 is a cooperative effort between the state of California, private industry, venture capital, and the University of California campuses at Berkeley, San Francisco, and Santa Cruz. At QB3-Berkeley, scientists and engineers from diverse fields form a vibrant scientific community and collaborate in new ways, leading to significant research advances. The core research facilities at QB3 provide state of the art capabilities and serve academic and industry researchers through the University of California system. And the QB3 entrepreneurial program has led to some groundbreaking scientific discoveries. Biophysical Society TV takes you to the hills of Berkeley, California.
Smartphones aren’t simply an amazing convenience. In Africa they can be used to make a lifesaving diagnosis. In fact, scientists led by Dan Fletcher are hoping to use a souped-up smartphone microscope to help them eradicate a devastating disease called river blindness.
October 20, 2013
Humans have taken advantage of the metabolism of the tiny fungus called baker’s or brewer’s yeast to generate beer and wine from grains and fruits and to bake bread and other confections for millennia. Less appreciated is the fact that this organism has provided a living test tube in which to discover many of the fundamental functions necessary for all life. These processes include many of considerable importance for understanding the underlying basis of human diseases, and for producing therapeutic agents used clinically in human medicine. How research in yeast, much of it conducted at UC Berkeley, has contributed to our understanding and treatment of asthma, cancer, diabetes and malaria is discussed by Jeremy Thorner.
May 15, 2013
The Biomolecular Nanotechnology Center (BNC) combines biology, physics, chemistry, electrical and mechanical engineering and materials science all in one place. The center offers bioengineers the opportunity to fabricate and experiment with micro-fluidic devices. At the center, students and faculty are working to shrink the time, scale and expense of biological research, which will, among other things, improve the clinical implementation of medical advances.
February 8, 2013
Jay Keasling is profiled in CNN’s “The Next List” blog, which explores his pioneering research in the field of synthetic biology and the engineering of microbes to produce biofuels, medicines, and other products from simple ingredients like sugar cane and grass.
QB3-Berkeley’s Responsible Conduct of Research Seminar Series gives graduate students, postdoctoral scholars, faculty, and staff the knowledge and tools to guide them through the increasingly complex ethical issues that they will face during their careers.
January 19, 2012
Jamie Cate and student Jon Galazka are engineering yeast to ferment ethanol more efficiently.
December 1, 2011
How is a box score like a genome sequence? This starts a wee slow, but go with it: Computational biologists James Fraser (UCSF) and Michael Eisen (Berkeley) explain how obsessions with baseball stats led them — and can lead others — to be data-heavy biologists.
Alex Pines on his article “Dynamic-angle spinning of quadrupolar nuclei” K.T. Mueller, B.Q Sun, G.C. Chingas, J.W. Zwanziger, T. Terao, A. Pines, Journal of Magnetic Resonance, Vol. 86/3, 1990, Pages 470-487.
Video entitled “In vivo imaging and control of neural networks” presented by Ehud Isacoff for the Kavli Frontiers of Science symposium series.
Chris Barlow of Wareham Development and Douglas Crawford introduce QB3’s latest industry incubator which opened in July 2011.
Dan Fletcher describes his experience of spending a year in Washington D.C. as a White House Fellow. He discusses the role of science in policymaking and addresses the question of how scientists can be effective in influencing decisions in government.
In Graham Fleming’s lab, researchers are trying to produce the next generation of green power by mimicking photosynthesis and thus create a man-made version of the process that could supply us with renewable energy.
By custom-engineering yeast to produce the powerful antimalaria drug, artemisinin, Jay Keasling reduced the cost of the life-saving treatment from dollars to pennies per dose. Now Keasling is leading a team of researchers as they engineer bacteria to convert waste-plant material into the hydrocarbons that our economy relies upon. In this video Keasling discusses the new field of synthetic biology.
This lecture, “Looking for the Good News in your Genome,” by Jasper Rine was the kickoff event for the 2010 On the Same Page program in the College of Letters and Science delivered on September 13, 2010 in Wheeler Auditorium.
Eva Nogales reviews the physical principles underlying image formation by the interaction of electrons with matter and introduces basic and advanced instruments and sample preparation techniques. Using a number of biological examples from work in her lab, she describes the capabilities of the Transmission electron microscopy (TEM) methodology. Special emphasis is placed on the image processing methods used to obtain three-dimensional information from TEM data.
Carlos Bustamante and John Kuriyan discuss the possibility of creating simple life forms in the laboratory.
In an appearance on Comedy Central’s “The Colbert Report,” Berkeley chemical engineering professor Jay Keasling explains how he and his colleagues at the Joint BioEnergy Institute are engineering bacteria to produce fuel from sugar, as well as to synthesize a low-cost anti-malarial drug.
The Colbert Report (video)
David Schaffer, associate director of the Berkeley Stem Cell Center, talks about stem cell research at UC Berkeley and how funds from CIRM are helping build improved research facilities in the Li Ka Shing Center for Biomedical and Health Sciences.
Stanley Hall was built to accommodate a highly interdisciplinary approach to bioscience research, targeting new treatments for diseases, more environmentally friendly sources of energy and better ways to clean up pollutants. This series of videos includes interviews with Professor Susan Marqusee who tells about the vision of Stanley Hall, Bio-engineering lecturer Terry Johnson, Mechanical Engineering graduate student Jeanne Stachowiak, and Chemistry Professor David Wemmer.